Renal Research Unit
31 – 40 of 102
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Renal Transplant Patients at High Risk of Acute Rejection Benefit From Adequate Exposure to Mycophenolic Acid.
(
- Contribution to journal › Article
-
Mark
Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
2010) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 25. p.2004-2010(
- Contribution to journal › Article
- 2009
-
Mark
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study
(
- Contribution to journal › Article
-
Mark
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
(
- Contribution to journal › Article
-
Mark
Relationship of tacrolimus exposure and MMF (cellcept (R)) dose with renal function at one year after renal transplantation
(
- Contribution to journal › Published meeting abstract
-
Mark
A wider repertoire and increased titers of carbohydrate-specific antibodies in mice rejecting adult porcine islets
2009) Joint Meeting of the International-Pancreas-and-Islet-Transplant-Association/International-Xe notransplantation-Association In Xenotransplantation 16(5). p.367-367(
- Contribution to journal › Published meeting abstract
-
Mark
More on B-Cell-Depleting Induction Therapy and Acute Cellular Rejection.
(
- Contribution to journal › Letter
-
Mark
Subgroup Analyses in Randomized Controlled Trials: The Need for Risk Stratification in Kidney Transplantation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation
(
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life of Patients Receiving Low-toxicity Immunosuppressive Regimens:. A Substudy of the Symphony Study
(
- Contribution to journal › Article